Milestone Pharmaceuticals Inc.
MIST· Nasdaq
Released Mar 24, 2022, before the open
10-K filed Mar 24, 2022, 83 days after period end · 0001558370-22-004205
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$16.88M | -$8.67M | -$18.29M | -$9.72M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2021 · filed Mar 24, 2022 · 83 d after period end
+13.5% from the close of Mar 23, 2022 to the close of Mar 25, 2022, the first after the release.